Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Thi Nguyen and Katherine Kedzierska.
Connection Strength

6.004
  1. CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity. Immunity. 2021 05 11; 54(5):1066-1082.e5.
    View in: PubMed
    Score: 0.940
  2. Perturbed CD8+ T cell immunity across universal influenza epitopes in the elderly. J Leukoc Biol. 2018 02; 103(2):321-339.
    View in: PubMed
    Score: 0.748
  3. Understanding CD8+ T-cell responses toward the native and alternate HLA-A*02:01-restricted WT1 epitope. Clin Transl Immunology. 2017 Mar; 6(3):e134.
    View in: PubMed
    Score: 0.708
  4. SARS-CoV-2-specific CD8+ T-cell responses and TCR signatures in the context of a prominent HLA-A*24:02 allomorph. Immunol Cell Biol. 2021 10; 99(9):990-1000.
    View in: PubMed
    Score: 0.238
  5. Robust correlations across six SARS-CoV-2 serology assays detecting distinct antibody features. Clin Transl Immunology. 2021; 10(3):e1258.
    View in: PubMed
    Score: 0.233
  6. Integrated immune dynamics define correlates of COVID-19 severity and antibody responses. Cell Rep Med. 2021 03 16; 2(3):100208.
    View in: PubMed
    Score: 0.232
  7. Influenza, but not SARS-CoV-2, infection induces a rapid interferon response that wanes with age and diminished tissue-resident memory CD8+ T cells. Clin Transl Immunology. 2021; 10(1):e1242.
    View in: PubMed
    Score: 0.232
  8. Suboptimal SARS-CoV-2-specific CD8+ T cell response associated with the prominent HLA-A*02:01 phenotype. Proc Natl Acad Sci U S A. 2020 09 29; 117(39):24384-24391.
    View in: PubMed
    Score: 0.226
  9. Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19. Nat Med. 2020 04; 26(4):453-455.
    View in: PubMed
    Score: 0.219
  10. Recalling the Future: Immunological Memory Toward Unpredictable Influenza Viruses. Front Immunol. 2019; 10:1400.
    View in: PubMed
    Score: 0.208
  11. Downregulation of MHC Class I Expression by Influenza A and B Viruses. Front Immunol. 2019; 10:1158.
    View in: PubMed
    Score: 0.206
  12. Human CD8+ T cell cross-reactivity across influenza A, B and C viruses. Nat Immunol. 2019 05; 20(5):613-625.
    View in: PubMed
    Score: 0.202
  13. With a Little Help from T Follicular Helper Friends: Humoral Immunity to Influenza Vaccination. J Immunol. 2019 01 15; 202(2):360-367.
    View in: PubMed
    Score: 0.201
  14. Single-Cell Approach to Influenza-Specific CD8+ T Cell Receptor Repertoires Across Different Age Groups, Tissues, and Following Influenza Virus Infection. Front Immunol. 2018; 9:1453.
    View in: PubMed
    Score: 0.194
  15. Clonally diverse CD38+HLA-DR+CD8+ T cells persist during fatal H7N9 disease. Nat Commun. 2018 02 26; 9(1):824.
    View in: PubMed
    Score: 0.189
  16. Circulating TFH cells, serological memory, and tissue compartmentalization shape human influenza-specific B cell immunity. Sci Transl Med. 2018 02 14; 10(428).
    View in: PubMed
    Score: 0.189
  17. Innate and adaptive T cells in influenza disease. Front Med. 2018 Feb; 12(1):34-47.
    View in: PubMed
    Score: 0.188
  18. Structural basis of biased T cell receptor recognition of an immunodominant HLA-A2 epitope of the SARS-CoV-2 spike protein. J Biol Chem. 2021 09; 297(3):101065.
    View in: PubMed
    Score: 0.060
  19. Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection. PLoS Pathog. 2021 07; 17(7):e1009759.
    View in: PubMed
    Score: 0.060
  20. Temporal differences in culturable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) from the respiratory and gastrointestinal tracts in a patient with moderate coronavirus disease 2019 (COVID-19). Infect Control Hosp Epidemiol. 2021 May 10; 1-3.
    View in: PubMed
    Score: 0.059
  21. Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial. Lancet Infect Dis. 2021 10; 21(10):1383-1394.
    View in: PubMed
    Score: 0.059
  22. Systems serology detects functionally distinct coronavirus antibody features in children and elderly. Nat Commun. 2021 04 01; 12(1):2037.
    View in: PubMed
    Score: 0.059
  23. A Dual-Antigen Enzyme-Linked Immunosorbent Assay Allows the Assessment of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in a Low-Transmission Setting. J Infect Dis. 2021 01 04; 223(1):10-14.
    View in: PubMed
    Score: 0.058
  24. The Dynamics of the Ferret Immune Response During H7N9 Influenza Virus Infection. Front Immunol. 2020; 11:559113.
    View in: PubMed
    Score: 0.057
  25. A serological assay to detect SARS-CoV-2 seroconversion in humans. Nat Med. 2020 07; 26(7):1033-1036.
    View in: PubMed
    Score: 0.055
  26. The Drivers of Pathology in Zoonotic Avian Influenza: The Interplay Between Host and Pathogen. Front Immunol. 2018; 9:1812.
    View in: PubMed
    Score: 0.049
  27. Influenza-specific lung-resident memory T cells are proliferative and polyfunctional and maintain diverse TCR profiles. J Clin Invest. 2018 02 01; 128(2):721-733.
    View in: PubMed
    Score: 0.047
  28. Fc functional antibodies in humans with severe H7N9 and seasonal influenza. JCI Insight. 2017 Jul 06; 2(13).
    View in: PubMed
    Score: 0.045
  29. Quantifiable predictive features define epitope-specific T cell receptor repertoires. Nature. 2017 07 06; 547(7661):89-93.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.